CAPS-5 PTSD scale
MDMA shows promise for PTSD treatment in second phase 3 trial, paving way for FDA approval
Anika Sharma
MAPS Public Benefit Corporation has recently unveiled phase 3 data, marking a significant milestone in its quest for FDA approval ...
